These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7868226)

  • 1. Infection of SCID mice with Mycobacterium leprae and control with antigen-activated "immune" human peripheral blood mononuclear cells.
    Converse PJ; Haines VL; Wondimu A; Craig LE; Meyers WM
    Infect Immun; 1995 Mar; 63(3):1047-54. PubMed ID: 7868226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of Mycobacterium leprae immunity in severe combined immunodeficient mice using a T-cell line.
    Azouaou N; Gelber RH; Abel K; Sasaki DT; Murray LP; Locksley RM; Mohagheghpour N
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):398-405. PubMed ID: 8228438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of severe combined immunodeficient (SCID) mice to Mycobacterium leprae: multiplication of the bacillus and dissemination of the infection at early stage.
    Yogi Y; Nakamura K; Inoue T; Kawatsu K; Kashiwabara Y; Sakamoto Y; Izumi S; Saito M; Hioki K; Nomura T
    Nihon Rai Gakkai Zasshi; 1991; 60(3-4):139-45. PubMed ID: 1843227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.
    Raman VS; O'Donnell J; Bailor HR; Goto W; Lahiri R; Gillis TP; Reed SG; Duthie MS
    Infect Immun; 2009 Dec; 77(12):5623-30. PubMed ID: 19786561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.
    Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J
    Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients.
    Brett SJ; Kingston AE; Colston MJ
    Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
    Aarestrup FM; Sampaio EP; de Moraes MO; Albuquerque EC; Castro AP; Sarno EN
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interruption of persistent exposure to leprosy combined or not with recent BCG vaccination enhances the response to Mycobacterium leprae specific antigens.
    de Carvalho FM; Rodrigues LS; Duppre NC; Alvim IMP; Ribeiro-Alves M; Pinheiro RO; Sarno EN; Pessolani MCV; Pereira GMB
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005560. PubMed ID: 28467415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with Mycobacterium bovis BCG and Mycobacterium leprae.
    Mustafa AS; Lundin KE; Oftung F
    Infect Immun; 1993 Dec; 61(12):5294-301. PubMed ID: 8225603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
    Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
    Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.
    Black GF; Weir RE; Chaguluka SD; Warndorff D; Crampin AC; Mwaungulu L; Sichali L; Floyd S; Bliss L; Jarman E; Donovan L; Andersen P; Britton W; Hewinson G; Huygen K; Paulsen J; Singh M; Prestidge R; Fine PE; Dockrell HM
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):602-11. PubMed ID: 12853392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients.
    Kaleab B; Ottenoff T; Converse P; Halapi E; Tadesse G; Rottenberg M; Kiessling R
    Eur J Immunol; 1990 Dec; 20(12):2651-9. PubMed ID: 2269329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae.
    Triccas JA; Roche PW; Winter N; Feng CG; Butlin CR; Britton WJ
    Infect Immun; 1996 Dec; 64(12):5171-7. PubMed ID: 8945562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study on the effects of rIL-4, rIL-2, rIFN-gamma, and rTNF-alpha on specific T-cell non-responsiveness to mycobacterial antigens in lepromatous leprosy patients in vitro.
    Ottenhoff TH; Wondimu A; Reddy NN
    Scand J Immunol; 1990 May; 31(5):553-65. PubMed ID: 2111939
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Bezerra-Santos M; do Vale-Simon M; Barreto AS; Cazzaniga RA; de Oliveira DT; Barrios MR; Ferreira AR; Santos-Bio NC; Reed SG; de Almeida RP; Corrêa CB; Duthie MS; de Jesus AR
    Front Immunol; 2018; 9():2920. PubMed ID: 30631322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular, humoral, and gamma interferon responses to Mycobacterium leprae and BCG antigens in healthy individuals exposed to leprosy.
    Converse PJ; Ottenhoff TH; Gebre N; Ehrenberg JP; Kiessling R
    Scand J Immunol; 1988 May; 27(5):515-25. PubMed ID: 3131867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.